What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.37%Below 5Y avg (0.97%)
Annual Rate
CNY 0.07Paid annual
Payout Ratio
112.7%High
Last Ex-Dividend
Jan 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.54BCNY
2.02B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
173.18x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue (TTM)
3.44BCNY
513.26M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
2.37%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Beta
0.5500x
vs all stocks
Updated Sep 22, 2026
52-Week Change
-37.36%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
13.54BCNY
2.02B · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
12.16BCNY
1.82B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
173.18x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Forward P/E
30.24x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Price to Sales (TTM)
3.94x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Price to Book (MRQ)
1.64x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Enterprise to Revenue
3.54x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Enterprise to EBITDA
79.98x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 34.39×.Updated Sep 22, 2026
Gross Margin
31.35%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 20.66%.Updated Sep 22, 2026
Profit Margin
2.37%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Margin
3.91%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Assets (TTM)
0.16%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Equity (TTM)
1.15%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue (TTM)
3.44BCNY
513.26M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
4.84CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
-13.70%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Gross Profit (TTM)
710.05MCNY
106.03M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
353.46MCNY
52.78M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
81.33MCNY
12.15M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
-53.40%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
245.79MCNY
36.70M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-48.67MCNY
-7.27M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing Annual Dividend Rate
0.0700CNYUpdated Sep 22, 2026
Trailing Annual Dividend Yield
0.37%
vs all stocks
Updated Sep 22, 2026
5-Year Average Dividend Yield
0.97%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
112.66%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 63.64%.Updated Sep 22, 2026
Minority Interest (Equity)
279.55MCNYFY2025 · Dec 31, 2025
Revenue
3.54BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.71BCNYFY2025 · Dec 31, 2025
Gross Profit
824.07MCNYFY2025 · Dec 31, 2025
Operating Income
180.77MCNY
26.99M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
143.88MCNYFY2025 · Dec 31, 2025
Income Tax Expense
3.80MCNYFY2025 · Dec 31, 2025
Net Income
140.07MCNYFY2025 · Dec 31, 2025
EBIT
163.59MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
353.46MCNYFY2025 · Dec 31, 2025
Research & Development
348.94MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
68.34MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
36.89MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
20.93MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
19.72MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1696CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1696CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
710.82MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
710.82MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
140.07MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-19.52MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
148.30MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-39.85MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.58BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
140.07MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
16.41MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-296.41MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
288.23MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-188.14MCNYFY2025 · Dec 31, 2025
Other Investing Activity
93.87MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-94.27MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
418.65MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-432.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-58.72MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-35.81MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-107.88MCNYFY2025 · Dec 31, 2025
Shares Outstanding
710.63MSharesUpdated Sep 22, 2026
Float Shares
254.60MSharesUpdated Sep 22, 2026
% Held by Insiders
65.88%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
4.12%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
2.12BCNY
316.00M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
2.98CNYUpdated Sep 22, 2026
Total Debt (MRQ)
732.31MCNY
109.36M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.0857x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Current Ratio (MRQ)
3.54x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
11.63CNYUpdated Sep 22, 2026
Total Assets
11.85BCNY
1.77B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
9.46BCNYFY2025 · Dec 31, 2025
Total Liabilities
3.40BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.40BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
453.92MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.94BCNYFY2025 · Dec 31, 2025
Cash
1.05BCNYFY2025 · Dec 31, 2025
Cash Equivalents
27.27MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
2.48BCNYFY2025 · Dec 31, 2025
Accounts Receivable
4.35BCNYFY2025 · Dec 31, 2025
Inventory
1.36BCNYFY2025 · Dec 31, 2025
Accounts Payable
1.98BCNYFY2025 · Dec 31, 2025
Short-term Debt
408.29MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
110.48MCNYFY2025 · Dec 31, 2025
Long-term Debt
310.85MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
16.54MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
710.63MCNYFY2025 · Dec 31, 2025
Retained Earnings
4.25BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
8.45BCNY
1.26B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
16.83CNYUpdated Sep 22, 2026
52-Week High
34.18CNYUpdated Sep 22, 2026
52-Week Change
-37.36%
vs all stocks
Updated Sep 22, 2026
Beta
0.5500x
vs all stocks
Updated Sep 22, 2026
50-Day MA
18.20CNYUpdated Sep 22, 2026
200-Day MA
23.09CNYUpdated Sep 22, 2026
Avg 10-Day Volume
9.09MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
6.91MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
0.1100CNYUpdated Sep 22, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 1.64×, lower than 95% of its Scientific & Technical Instruments peers (median 5.57×)Notable